#$%^&*AU2018204100A120180628.pdf#####ABSTRACT In certain aspects, the present invention provides methods for dosing a patient with an activin-ActRIla antagonist and methods for managing patients treated with an activinActRIIa anatagonist. In certain aspects, the methods involve measuring one or more 5 hematologic parameters in a patient.